Clopidogrel in Infants with Systemic-to-Pulmonary-Artery Shunts
Author(s) -
David Wessel,
Felix Berger,
Jennifer S. Li,
Ingo Dähnert,
Amit Rakhit,
Sylvie Fontecave,
Jane W. Newburger
Publication year - 2013
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1114588
Subject(s) - medicine , clopidogrel , cardiology , pulmonary artery , anesthesia , myocardial infarction
Infants with cyanotic congenital heart disease palliated with placement of a systemic-to-pulmonary-artery shunt are at risk for shunt thrombosis and death. We investigated whether the addition of clopidogrel to conventional therapy reduces mortality from any cause and morbidity related to the shunt.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom